Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02688166 · ClinicalTrials.gov registry record
Cardiac MRI Biomarker Testing (GCC 1618)
A clinical trial, sponsored by University of Maryland, Baltimore.
- Terminated
- Registry status
- 6
- Enrollment target
NCT02688166 is a clinical trial that was terminated before completion, run by University of Maryland, Baltimore. The registered enrollment target is 6 participants.
The verdict
NCT02688166 was terminated before completion, sponsored by University of Maryland, Baltimore.
- TERMINATED
- Registry status
- 6 participants
- Enrollment target
Study Summary
This research study can help understand how cardiac changes may occur with radiation therapy to the heart based off measurements obtained through biomarkers and cardiac imaging. Researchers plan to perform cardiac imaging and biomarkers for any cardiac injury. Cardiac magnetic resonance imaging (CMR) provides the ability to quantitatively measure cardiac function and injury. The cardiac biomarkers that will be tested are effective in the diagnosis, risk-stratification, and monitoring of heart failure.
Interventions
- OTHER Complete Cardiac Magnetic Resonance Imaging (MRI)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2018-02-01 |
| Est. Completion | 2022-09-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02688166
The ClinicalTrials.gov registry entry for NCT02688166 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Complete Cardiac Magnetic Resonance Imaging (MRI) is the first listed.
NCT02688166 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02688166 about?
NCT02688166 is a clinical study titled "Cardiac MRI Biomarker Testing (GCC 1618)". This research study can help understand how cardiac changes may occur with radiation therapy to the heart based off measurements obtained through biomarkers and cardiac imaging. Researchers plan to perform cardiac imaging and biomarkers for any cardiac injury. Cardiac magnetic resonance imaging (CM...
What is the current status of trial NCT02688166?
This trial is currently terminated. The enrollment target is 6 participants. The study started on 2018-02-01. Estimated completion is 2022-09-09.
What interventions are being tested in trial NCT02688166?
The interventions under investigation include: Complete Cardiac Magnetic Resonance Imaging (MRI) (OTHER).
Who is sponsoring clinical trial NCT02688166?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.